HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Meta-analysis of MMP2, MMP3, and MMP9 promoter polymorphisms and head and neck cancer risk.

AbstractBACKGROUND:
The 1306 C>T, 1171 5A>6A, and 1562C>T polymorphisms of matrix metalloproteinase (MMP) 2, MMP3, and MMP9 genes, respectively, have been found to be functional and may contribute to head and neck carcinogenesis. However, the results of case-control studies examining associations between MMP polymorphisms and head and neck cancer (HNC) risk remain inconclusive. Therefore, we performed a meta-analysis to further evaluate the role of these polymorphisms in HNC development.
METHODS:
We searched PubMed, ISI Web of Knowledge, MEDLINE, Embase, and Google Scholar to identify all published case-control studies of MMP2-1306 C>T, MMP3-1171 5A>6A, and MMP9-1562 C>T polymorphisms and HNC risk in the meta-analysis. Odds ratios (ORs) and 95% confidence intervals (CIs) were used to assess the association between these polymorphisms and HNC risk.
RESULTS:
Thirteen studies were included in this meta-analysis. For MMP2-1306 C>T polymorphism, significant associations were observed under three genetic models both in overall comparison and in a hospital-based subgroup, and in oral cavity cancer and nasopharyngeal cancer under dominant model as well. For MMP3-1171 5A>6A and MMP9-1562 C>T polymorphisms, no association was found in overall comparison; however, in subgroup analyses based on ethnicity and tumor site, significant associations were detected between the MMP3-1171 5A>6A polymorphism and HNC risk in a European population and pharyngeal/laryngeal cancer under two genetic contrasts.
CONCLUSION:
This meta-analysis suggests that the MMP2-1306 C>T polymorphism is associated with HNC risk, as is the MMP3-1171 5A>6A polymorphism specifically in some subgroups. Further studies with larger sample sizes are warranted.
AuthorsCaiyun Zhang, Chao Li, Minhui Zhu, Qingzhou Zhang, Zhenghua Xie, Gang Niu, Xicheng Song, Lei Jin, Guojun Li, Hongliang Zheng
JournalPloS one (PLoS One) Vol. 8 Issue 4 Pg. e62023 ( 2013) ISSN: 1932-6203 [Electronic] United States
PMID23637955 (Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't)
Chemical References
  • Matrix Metalloproteinase 3
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 9
Topics
  • Alleles
  • Case-Control Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Head and Neck Neoplasms (genetics)
  • Humans
  • Matrix Metalloproteinase 2 (genetics)
  • Matrix Metalloproteinase 3 (genetics)
  • Matrix Metalloproteinase 9 (genetics)
  • Odds Ratio
  • Polymorphism, Single Nucleotide
  • Promoter Regions, Genetic
  • Publication Bias
  • Risk

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: